Hyderabad India-based Bharat Biotech, a major vaccines and bio-therapeutics manufacturer in India, announced a collaboration with Bilthoven Biologicals B.V., the Netherlands-based wholly-owned subsidiary of Serum Institute of India. The partnership aims to strengthen the production and supply security of oral polio vaccines. Polio, or poliomyelitis, is a highly contagious and...
India’s Serum Institute Invests in IntegriMedical of Indiana
Pune-based Serum Institute of India (SII) announced a strategic investment in IntegriMedical, based in Bainbridge, IN. where SII will acquire a 20% stake in the company. This partnership aims to advance IntegriMedical's Needle-Free Injection System (N-FIS) technology, aligning with SII's vision of 'Health for All' and IntegriMedical's mission to 'Transform...
Serum Institute of India to Stockpile Vaccines for the World
On the outskirts of Pune, in India's western state of Maharashtra, at the 100-acre campus of Serum Institute of India (SII), CEO Adar Poonawalla proposes to set up a plug-and-play vaccine-making facility in preparation for the next pandemic. Since the facility can handle all different technologies, Poonawalla has offered 300,000 sq...
Serum Institute of India Partners with SCHOTT AG for Pharmaceutical Packaging
Germany's specialty glass company SCHOTT AG and Serum Institute of India, the world‘s largest vaccine producer and manufacturer of biologics, have formed a joint venture for pharma packaging products such as vials, syringes, ampoules and cartridges. Serum Institute bought the 50% stake in the Indian joint venture SCHOTT Kaisha from...